‘Dip in pharma exports due to shifting of mfg bases’

Shifting of manufacturing bases to over seas markets by certain domestic companies and absence of block buster drugs going off-patent are some of reasons for di pin India’ s pharmaceutical exports, Parliament was informed on Wednesday. In2016-17, the exports decreased by 0.43 per cent in value terms and 6.95 per cent in volume terms, Minister of State for Commerce and Industry CR Ch aud ha rysai din a written reply to a question in the Rajya Sabha.